Jasper Therapeutics | SC 13G:超过5%持股股东披露文件-Avidity Partners Management LP(5.1%),Avidity Partners Management (GP) LLC(5.1%)等
Jasper Therapeutics | 4:持股变动声明-高管 Mahal Jeetinder Singh
Jasper Therapeutics | 4:持股变动声明-高管 MARTELL RON
Jasper Therapeutics | 4:持股变动声明-高管 Mahal Jeetinder Singh
Jasper Therapeutics | 4:持股变动声明-高管 CROSS HERB
Jasper Therapeutics | 4:持股变动声明-高管 Tucker Edwin Jonathan
Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Securities LLC(0.2%),Citadel Securities Group LP(0.2%)等
Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Qiming U.S. Healthcare Fund II, L.P.(6.2%),Qiming U.S. Healthcare GP II, LLC(6.2%)等
Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等
Jasper Therapeutics | 4:持股变动声明- Carlyle Group Inc.
Jasper Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-The Carlyle Group Inc.(7.1%),Carlyle Holdings I GP Inc.(7.1%)等
Jasper Therapeutics | 4:持股变动声明-股东 Velan Capital Investment Management LP
Jasper Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Velan Capital Investment Management LP(9.8%),Velan Capital Management LLC(9.8%)等
Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Sphera Funds Management Ltd.(6.39%),Sphera Global Healthcare GP Ltd.(6.39%)等
Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Soleus Capital Master Fund, L.P.(8.8%),Soleus Capital, LLC(8.8%)等
Jasper Therapeutics | 4:持股变动声明-董事 WIGGANS THOMAS G
Jasper Therapeutics | 4:持股变动声明-董事 WIGGANS THOMAS G
Jasper Therapeutics | 4:持股变动声明-董事 WIGGANS THOMAS G
Jasper Therapeutics | 4:持股变动声明-董事 WIGGANS THOMAS G
Jasper Therapeutics | 3:首次持股声明-董事 WIGGANS THOMAS G
暂无数据